Clinical Research Directory

Inclusion Criteria: \- Adults aged 60 years and older who are physically capable of participating in study procedures; willing to be randomized to fisetin or placebo; weight stable within the previous 2 months (\<5-pound change); no blood donation within 2 months before screening; absence of unstable chronic disease; willing to maintain baseline activity level throughout the study; body mass index \<30 kg/m²; and either a history of at least 10 pack-years of cigarette smoking or never-smoking status. Exclusion Criteria: * Electrocardiogram (ECG) abnormalities, including prolonged QTc. * Use of fisetin, other flavonoid supplements, or known senolytic compounds within 6 months prior to screening. * Resting systolic blood pressure \>160 mmHg or diastolic blood pressure \>110 mmHg. * Known allergy or hypersensitivity to fisetin or any component of the study product. * Active malignancy, except non-melanoma skin cancer. * Clinically significant hepatic, renal, cardiovascular, endocrine, immunologic, metabolic, or other uncontrolled medical conditions that, in the opinion of the investigator, would interfere with study participation or interpretation of results. * Clinically significant laboratory abnormalities, including severe anemia, leukopenia, thrombocytopenia, uncontrolled diabetes, advanced kidney disease, significant liver dysfunction, or evidence of systemic inflammation. * Human immunodeficiency virus (HIV) infection, active hepatitis B or hepatitis C infection, or invasive fungal infection. * History of diverticulitis or diverticulosis with gastrointestinal bleeding. * Current use of systemic corticosteroids. * Current use of warfarin. * Current use of medications with significant interaction potential with fisetin, including selected CYP450 or transporter substrates, inhibitors, or inducers, unless such medications can be safely withheld according to protocol requirements. * Recent medication, supplement, or lifestyle changes that may affect study outcomes, in the opinion of the investigator. * Inability to perform required study procedures, including pulmonary function testing, exercise testing, or other protocol assessments. * Unwillingness or inability to provide informed consent. * Pregnancy or breastfeeding. * Any other condition that, in the opinion of the investigator, would make participation unsafe or compromise study integrity.